Adenocarcinoma  >>  Xcytrin (motexafin gadolinum)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Xcytrin (motexafin gadolinum) / AbbVie
NCT00102505: A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)

Completed
1
36
US
Motexafin Gadolinium Injection
Pharmacyclics LLC.
Non-Small-Cell Lung Carcinoma, Carcinoma, Bronchogenic
 
 
NCT00003798: Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery

Completed
1
45
US
motexafin gadolinium, radiation therapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, National Cancer Institute (NCI)
Pancreatic Cancer
 
 

Download Options